ReP USP - Resultado da busca

Artigo de periodico
Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism (2021)
Neto-Neves, Evandro Manoel; Sousa-Santos, Ozelia; Ferraz, Karina C.; Portella, Rafael L.; Sertorio, Jonas T.; Tanus-Santos, José Eduardo
Source: Nitric Oxide. Unidade: FMRP
Subjects: DOENÇA AGUDA, TROMBOFLEBITE, ANTIOXIDANTES, VENTRÍCULO CARDÍACO, HIPERTENSÃO PULMONAR, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETO-NEVES, Evandro Manoel et al. Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism. Nitric Oxide, v. 115, p. 23-29, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2021.06.004. Acesso em: 05 nov. 2024.
APA
Neto-Neves, E. M., Sousa-Santos, O., Ferraz, K. C., Portella, R. L., Sertorio, J. T., & Tanus-Santos, J. E. (2021). Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism. Nitric Oxide, 115, 23-29. doi:10.1016/j.niox.2021.06.004
NLM
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Portella RL, Sertorio JT, Tanus-Santos JE. Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism [Internet]. Nitric Oxide. 2021 ; 115 23-29.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.niox.2021.06.004
Vancouver
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Portella RL, Sertorio JT, Tanus-Santos JE. Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism [Internet]. Nitric Oxide. 2021 ; 115 23-29.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.niox.2021.06.004
Artigo de periodico
Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism (2013)
Neto-Neves, Evandro M.; Sousa-Santos, Ozelia; Ferraz, Karina C.; Rizzi, Elen; Ceron, Carla S.; Romano, Minna Moreira Dias; Gali, Luis G.; Maciel, Benedito Carlos; Schulz, Richard; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Journal of Cellular and Molecular Medicine. Unidades: FMRP, FORP
Subjects: TROMBOEMBOLISMO, METALOPROTEINASES, HIPERTENSÃO PULMONAR, MIOCARDIOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETO-NEVES, Evandro M. et al. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism. Journal of Cellular and Molecular Medicine, v. 17, n. 12, p. 1588-1597, 2013Tradução . . Disponível em: https://doi.org/10.1111/jcmm.12163. Acesso em: 05 nov. 2024.
APA
Neto-Neves, E. M., Sousa-Santos, O., Ferraz, K. C., Rizzi, E., Ceron, C. S., Romano, M. M. D., et al. (2013). Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism. Journal of Cellular and Molecular Medicine, 17( 12), 1588-1597. doi:10.1111/jcmm.12163
NLM
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Rizzi E, Ceron CS, Romano MMD, Gali LG, Maciel BC, Schulz R, Gerlach RF, Tanus-Santos JE. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism [Internet]. Journal of Cellular and Molecular Medicine. 2013 ; 17( 12): 1588-1597.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/jcmm.12163
Vancouver
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Rizzi E, Ceron CS, Romano MMD, Gali LG, Maciel BC, Schulz R, Gerlach RF, Tanus-Santos JE. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism [Internet]. Journal of Cellular and Molecular Medicine. 2013 ; 17( 12): 1588-1597.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/jcmm.12163
Artigo de periodico
The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption (2013)
Sousa-Santos, Ozelia; Neto-Neves, Evandro M.; Ferraz, Karina C.; Sertório, Jonas T.; Portella, Rafael L.; Tanus-Santos, José Eduardo
Source: Thrombosis Research. Unidade: FMRP
Subjects: ANTIOXIDANTES (APLICAÇÕES TERAPÊUTICAS), HEMODINÂMICA (EFEITOS DE DROGAS), ÓXIDO NÍTRICO, ESTRESSE OXIDATIVO, EMBOLIA PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA-SANTOS, Ozelia et al. The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption. Thrombosis Research, v. 132, n. 5, p. 578-583, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.thromres.2013.09.014. Acesso em: 05 nov. 2024.
APA
Sousa-Santos, O., Neto-Neves, E. M., Ferraz, K. C., Sertório, J. T., Portella, R. L., & Tanus-Santos, J. E. (2013). The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption. Thrombosis Research, 132( 5), 578-583. doi:10.1016/j.thromres.2013.09.014
NLM
Sousa-Santos O, Neto-Neves EM, Ferraz KC, Sertório JT, Portella RL, Tanus-Santos JE. The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption [Internet]. Thrombosis Research. 2013 ; 132( 5): 578-583.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.thromres.2013.09.014
Vancouver
Sousa-Santos O, Neto-Neves EM, Ferraz KC, Sertório JT, Portella RL, Tanus-Santos JE. The antioxidant tempol decreases acute pulmonary thromboembolism-induced hemolysis and nitric oxide consumption [Internet]. Thrombosis Research. 2013 ; 132( 5): 578-583.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.thromres.2013.09.014
Artigo de periodico
Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses (2013)
Ferraz, Karina C.; Sousa-Santos, Ozélia; Neto-Neves, Evandro M.; Rizzi, Ellen; Muniz, Jaqueline J.; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Basic and Clinical Pharmacology and Toxicology. Unidades: FORP, FMRP
Subjects: RECEPTORES ADRENÉRGICOS, PROTEÍNAS RECOMBINANTES, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAZ, Karina C. et al. Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses. Basic and Clinical Pharmacology and Toxicology, v. 112, n. 2, p. 103-109, 2013Tradução . . Disponível em: https://doi.org/10.1111/bcpt.12001. Acesso em: 05 nov. 2024.
APA
Ferraz, K. C., Sousa-Santos, O., Neto-Neves, E. M., Rizzi, E., Muniz, J. J., Gerlach, R. F., & Tanus-Santos, J. E. (2013). Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses. Basic and Clinical Pharmacology and Toxicology, 112( 2), 103-109. doi:10.1111/bcpt.12001
NLM
Ferraz KC, Sousa-Santos O, Neto-Neves EM, Rizzi E, Muniz JJ, Gerlach RF, Tanus-Santos JE. Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses [Internet]. Basic and Clinical Pharmacology and Toxicology. 2013 ; 112( 2): 103-109.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/bcpt.12001
Vancouver
Ferraz KC, Sousa-Santos O, Neto-Neves EM, Rizzi E, Muniz JJ, Gerlach RF, Tanus-Santos JE. Recombinant human matrix metalloproteinase-2 impairs cardiovascular 'beta'-adrenergic responses [Internet]. Basic and Clinical Pharmacology and Toxicology. 2013 ; 112( 2): 103-109.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/bcpt.12001
Artigo de periodico
Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism (2012)
Sousa-Santos, Ozelia; Neves, Evandro M. Neto; Ferraz, Karina C.; Ceron, Carla S.; Rizzi, Elen; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Naunyn-Schmiedeberg's Archives Pharmacology. Unidades: FORP, FMRP
Subjects: ANTIOXIDANTES, TROMBOEMBOLISMO, METALOPROTEINASES, TROPONINA I
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA-SANTOS, Ozelia et al. Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism. Naunyn-Schmiedeberg's Archives Pharmacology, v. 385, n. 7, p. 685-696, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00210-012-0748-9. Acesso em: 05 nov. 2024.
APA
Sousa-Santos, O., Neves, E. M. N., Ferraz, K. C., Ceron, C. S., Rizzi, E., Gerlach, R. F., & Tanus-Santos, J. E. (2012). Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism. Naunyn-Schmiedeberg's Archives Pharmacology, 385( 7), 685-696. doi:10.1007/s00210-012-0748-9
NLM
Sousa-Santos O, Neves EMN, Ferraz KC, Ceron CS, Rizzi E, Gerlach RF, Tanus-Santos JE. Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism [Internet]. Naunyn-Schmiedeberg's Archives Pharmacology. 2012 ; 385( 7): 685-696.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00210-012-0748-9
Vancouver
Sousa-Santos O, Neves EMN, Ferraz KC, Ceron CS, Rizzi E, Gerlach RF, Tanus-Santos JE. Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism [Internet]. Naunyn-Schmiedeberg's Archives Pharmacology. 2012 ; 385( 7): 685-696.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s00210-012-0748-9

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em